Cargando…
Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension
Pulmonary hypertension (PH) is a progressive and fatal disease with no cure. Vascular remodeling in PH involves intraluminal growth of endothelial and smooth muscle cells, leading to obliterative vascular lesions. Cell growth in these lesions is quasi-neoplastic, with evidence of monoclonality, apop...
Autores principales: | Bauer, Eileen M., Zheng, Han, Lotze, Michael T., Bauer, Philip M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024039/ https://www.ncbi.nlm.nih.gov/pubmed/24837600 http://dx.doi.org/10.1371/journal.pone.0096720 |
Ejemplares similares
-
Complement C3 Deficiency Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension in Mice
por: Bauer, Eileen M., et al.
Publicado: (2011) -
Intraventricular recombinant alpha-interferon in subacute sclerosing panencephalitis
por: Cianchetti, C., et al.
Publicado: (1991) -
Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis C
por: Dhillon, Sonu, et al.
Publicado: (2010) -
Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis
por: Dawson, Rod, et al.
Publicado: (2009) -
Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
por: Baghizadeh, Somayyeh, et al.
Publicado: (2016)